| Scrip Code | 543249 |
|---|---|
| NSE Symbol | TARC |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0EK901012 |
| Name of company | TARC LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 11-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 04-11-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Real estate business |
| Start date and time of board meeting | 11-11-2025 16:00:00 |
| End date and time of board meeting | 11-11-2025 17:20:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 687.06 | 8,276.54 | |
| Other income | 2,722.98 | 24,670.11 | |
| Total income | 3,410.04 | 32,946.65 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 591.32 | 694.45 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 699.37 | 1,240.20 |
| (e) | Finance costs | 1,122.67 | 2,650.55 |
| (f) | Depreciation, depletion and amortisation expense | 240.43 | 481.23 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 2,960.29 | 21,937.43 |
| Total other expenses | 2,960.29 | 21,937.43 | |
| Total expenses | 5,614.08 | 27,003.86 | |
| 3 | Total profit before exceptional items and tax | (2,204.04) | 5,942.79 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | (2,204.04) | 5,942.79 |
| 6 | Tax expense | ||
| 7 | Current tax | 53.56 | 3,572.73 |
| 8 | Deferred tax | (681.01) | (1,474.76) |
| 9 | Total tax expenses | (627.45) | 2,097.97 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (1,576.59) | 3,844.82 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | (1,576.59) | 3,844.82 |
| 17 | Other comprehensive income net of taxes | 13.65 | 1.24 |
| 18 | Total Comprehensive Income for the period | (1,562.94) | 3,846.06 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | (1,575.70) | 3,847.59 | |
| Total profit or loss, attributable to non-controlling interests | (0.89) | (2.77) | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | (1,562.06) | 3,848.82 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | (0.89) | (2.77) | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 5,901.93 | 5,901.93 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -0.53 | 1.3 | |
| Diluted earnings (loss) per share from continuing operations | -0.53 | 1.3 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -0.53 | 1.3 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -0.53 | 1.3 | |
| 24 | Debt equity ratio | 1.81 | 1.81 |
| 25 | Debt service coverage ratio | -0.73 | 3.35 |
| 26 | Interest service coverage ratio | -0.75 | 3.42 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Please refer financial results PDF file already submitted with the exchange. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 39,912.10 | |
| Capital work-in-progress | 0.00 | |
| Investment property | 59,244.02 | |
| Goodwill | 27,751.29 | |
| Other intangible assets | 288.33 | |
| Intangible assets under development | 0.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 5,785.80 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | 27,110.75 | |
| Total non-current financial assets | 32,896.55 | |
| Deferred tax assets (net) | 12,524.59 | |
| Other non-current assets | 21,310.06 | |
| Total non-current assets | 1,93,926.94 | |
| 2 | Current assets | |
| Inventories | 2,27,345.64 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 1,003.74 | |
| Cash and cash equivalents | 11,155.42 | |
| Bank balance other than cash and cash equivalents | 1,850.25 | |
| Loans, current | 72.31 | |
| Other current financial assets | 5,830.46 | |
| Total current financial assets | 19,912.18 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | 13,642.85 | |
| Total current assets | 2,60,900.67 | |
| 3 | Non-current assets classified as held for sale | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | |
| Total assets | 4,54,827.61 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 5,901.93 | |
| Other equity | 1,02,242.50 | |
| Total equity attributable to owners of parent | 1,08,144.43 | |
| Non controlling interest | 25.67 | |
| Total equity | 1,08,170.10 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 1,74,169.31 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | ||
| Total Trade payable | ||
| Other non-current financial liabilities | 521.18 | |
| Total non-current financial liabilities | 1,74,690.49 | |
| Provisions, non-current | 360.83 | |
| Deferred tax liabilities (net) | 262.63 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | 0.00 | |
| Total non-current liabilities | 1,75,313.95 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 21,578.83 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 452.63 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 5,127.38 | |
| Total Trade payable | 5,580.01 | |
| Other current financial liabilities | 17,180.65 | |
| Total current financial liabilities | 44,339.49 | |
| Other current liabilities | 1,25,810.46 | |
| Provisions, current | 85.64 | |
| Current tax liabilities (Net) | 1,107.97 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 1,71,343.56 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 3,46,657.51 | |
| Total equity and liabilites | 4,54,827.61 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of net defined benefit liability/asset | 1809000 | -1259000 |
| Total Amount of items that will not be reclassified to profit and loss | 18.09 | (12.59) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 4.44 | (13.83) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 13.65 | 1.24 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 5,942.79 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 2,620.84 | |||||
| Adjustments for decrease (increase) in inventories | (22,551.01) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (16.17) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (2,312.57) | |||||
| Adjustments for decrease (increase) in other non-current assets | 655.40 | |||||
| Adjustments for other financial assets, non-current | 6,706.00 | |||||
| Adjustments for other financial assets, current | (7,200.50) | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (563.70) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 29,961.33 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 481.23 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | (2.11) | |||||
| Adjustments for provisions, non-current | 58.58 | |||||
| Adjustments for other financial liabilities, current | 1,096.70 | |||||
| Adjustments for other financial liabilities, non-current | 0.54 | |||||
| Adjustments for unrealised foreign exchange losses gains | 0.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 0.00 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 1.09 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 24.81 | |||||
| Total adjustments for reconcile profit (loss) | 8,960.46 | |||||
| Net cash flows from (used in) operations | 14,903.25 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | (29.73) | |||||
| Interest received | (321.71) | |||||
| Income taxes paid (refund) | 2,948.32 | |||||
| Other inflows (outflows) of cash | 14,795.69 | |||||
| Net cash flows from (used in) operating activities | 26,458.64 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.00 | |||||
| Purchase of property, plant and equipment | 1,995.29 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 3.48 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (1,945.10) | |||||
| Net cash flows from (used in) investing activities | (3,936.91) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 6,192.16 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 5,409.11 | |||||
| Payments of lease liabilities | 62.14 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 16,912.85 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (16,191.94) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 6,329.79 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 6,329.79 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 4,825.63 | |||||
| Cash and cash equivalents cash flow statement at end of period | 11,155.42 | |||||